[PSTX] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[PSTX] Poseida Therapeutics, Inc.
Announcement Date
12-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- -5,915,400.00%
YoY- -54.39%
Quarter Report
PSTX's Result
PSTX's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 9,921 116,306 2,700 1,435 31 0 0 -
PBT -33,026 70,661 -43,036 -58,057 1 -42,424 -45,705 -19.42%
Tax 292 252 1,491 1,096 -17,602 840 860 -51.23%
NP -33,318 70,409 -44,527 -59,153 1 -42,424 -45,705 -18.95%
Tax Rate - -0.36% - - 1,198,216.25% - - -
Total Cost 43,239 45,897 47,227 60,588 30 42,424 45,705 -3.62%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -335.85 60.54 -1,649.15 -4,122.16 4.70 0.00 0.00 -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.39 0.92 -0.71 -0.95 0.02 -0.68 -0.74 -34.67%
EPS Diluted -0.39 0.92 -0.71 -0.95 0.02 -0.68 -0.74 -34.67%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.